4 Results for "

valrubicin

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "valrubicin" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-13772
CAS No.: 56124-62-0
Purity:  99.60%
Synonyms: AD-32
Target:  

PKC Antibiotic

Research Areas:  

Inflammation/Immunology Cancer

Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively, and has antitumor and antiinflammatory activity.
loading...
    loading...
Cat. No.: HY-13772R
CAS No.: 56124-62-0
Synonyms: AD-32 (Standard)
Valrubicin (Standard) is the analytical standard of Valrubicin. This product is intended for research and analytical applications. Valrubicin is a chemotherapy agent, inhibits TPA-and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively, and has antitumor and antiinflammatory activity.
loading...
    loading...
Cat. No.: HY-P10453
Target:  

Peptides

Research Areas:  

Others

Myr5A peptide is an acylated peptide composed of apolipoprotein A1 (ApoA1) analog peptide 5A peptide coupled to the saturated fatty acid myristate. Myr5A peptide self-assembled into lipid nanostructures can be used to encapsulate anthracycline Doxorubicin (HY-15142A) and Valrubicin (HY-13772) for compound release studies in vitro .
loading...
    loading...
Cat. No.: HY-129878
CAS No.: 26295-56-7
Synonyms: AD-41
Target:  

Endogenous Metabolite

Research Areas:  

Cancer

N-Trifluoroacetyladriamycin (AD-41) is a chemotherapeutic compound with antitumor activity. N-Trifluoroacetyladriamycin exhibits the highest fluorescence and radioactivity levels in the small intestine and liver, indicating its significant accumulation in these tissues. N-Trifluoroacetyladriamycin also shows significant accumulation in the kidney, spleen, large intestine, lung, and heart. N-Trifluoroacetyladriamycin is a metabolite of Valrubicin, which is used to inhibit bladder cancer. The presence of N-Trifluoroacetyladriamycin and its derivatives may be related to the biotransformation of the compound and its antitumor mechanism .
loading...
    loading...